WO2023002431 - AUTOMATED SYNTHESIS OF POLYMERIC DRUGS
National phase entry:
Publication Number
WO/2023/002431
Publication Date
26.01.2023
International Application No.
PCT/IB2022/056757
International Filing Date
21.07.2022
Title **
[English]
AUTOMATED SYNTHESIS OF POLYMERIC DRUGS
[French]
SYNTHÈSE AUTOMATISÉE DE MÉDICAMENTS POLYMÈRES
Applicants **
SONY GROUP CORPORATION
1-7-1 Konan, Minato-ku
Tokyo, Tokyo 108-0075, JP
Inventors
MATRAY, Tracy
1730 N. First St.
San Jose, California 95112, US
VANBRUNT, Michael
1730 N. First St.
San Jose, California 95112, US
MCCUTCHEON, John Michael
1730 N. First St.
San Jose, California 95112, US
Priority Data
63/224,777
22.07.2021
US
63/250,892
30.09.2021
US
63/252,993
06.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 6141 | |
| EPO | Filing, Examination | 104901 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 640 | |
| USA | Filing, Examination | 32260 |
Total: 144533 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
, M, p, q, m, and n are as defined herein. Additional compounds, methods of preparation, pharmaceutical compositions, and methods of treatment related to compounds of Structure (I) are also provided.[French]
, M, p, q, m, et n sont tels que définis dans la description. L'invention concerne également des composés supplémentaires, des procédés de préparation, des compositions pharmaceutiques et des procédés de traitement associés à des composés de structure (I).